This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeon, J.-H. Articles by Choi, I. Search for Related Content PubMed PubMed Citation Articles by Jeon, J.-H. Articles by Choi, I.

Tumor Suppressor VDUP1 Increases p27^kip1 Stability by Inhibiting JAB1

Laboratories of ¹ Immunology and ² Functional Proteomics, Korea Research Institute of Bioscience and Biotechnology, ³ School of Bioscience and Biotechnology, Chungnam National University, Yusong, Taejon, Republic of Korea

Requests for reprints: Inpyo Choi, Laboratory of Immunology, Korea Research Institute of Bioscience and Biotechnology, Yusong, 305-333 Taejon, Republic of Korea. Phone: 82-42-860-4223; Fax: 82-42-860-4593; E-mail: ipchoi{at}kribb.re.kr.

Vitamin D₃ up-regulated protein 1 (VDUP1) is a stress-response gene that is up-regulated by 1,25(OH)₂D₃ in many cells. It has been reported that VDUP1 expression is reduced in many tumor cells and the enforced expression of VDUP1 inhibits cell proliferation by arresting cell cycle progression. Here, we found that VDUP1^–/– fibroblast cells proliferated more rapidly compared with wild-type cells with reduced expression of p27^kip1, a cyclin-dependent kinase inhibitor. JAB1 is known to interact with p27^kip1 and to decrease the stability of p27^kip1. VDUP1 interacted with JAB1 and restored JAB1-induced suppression of p27^kip1 stability. In this process, VDUP1 blocked the JAB1-mediated translocation of p27^kip1 from the nucleus to the cytoplasm. In addition, VDUP1 inhibited JAB1-mediated activator protein-1 activation and cell proliferation. Taken together, these results indicate that VDUP1 is a novel factor of p27^kip1 stability via regulating JAB1.

This article has been cited by other articles:

				F. Turturro, G. Von Burton, and E. Friday Hyperglycemia-Induced Thioredoxin-Interacting Protein Expression Differs in Breast Cancer-Derived Cells and Regulates Paclitaxel IC50 Clin. Cancer Res., June 15, 2007; 13(12): 3724 - 3730. [Abstract] [Full Text] [PDF]

				T. A. Dunn, S. Chen, D. A. Faith, J. L. Hicks, E. A. Platz, Y. Chen, C. M. Ewing, J. Sauvageot, W. B. Isaacs, A. M. De Marzo, et al. A Novel Role of Myosin VI in Human Prostate Cancer Am. J. Pathol., November 1, 2006; 169(5): 1843 - 1854. [Abstract] [Full Text] [PDF]

				N. Yabuta, H. Onda, M. Watanabe, N. Yoshioka, I. Nagamori, T. Funatsu, S. Toji, K. Tamai, and H. Nojima Isolation and characterization of the TIGA genes, whose transcripts are induced by growth arrest Nucleic Acids Res., October 18, 2006; 34(17): 4878 - 4892. [Abstract] [Full Text] [PDF]

				K.-H. Shin, M. K. Kang, R. H. Kim, R. Christensen, and N.-H. Park Heterogeneous Nuclear Ribonucleoprotein G Shows Tumor Suppressive Effect against Oral Squamous Cell Carcinoma Cells. Clin. Cancer Res., May 15, 2006; 12(10): 3222 - 3228. [Abstract] [Full Text] [PDF]

				C. M. Banwell, D. P. MacCartney, M. Guy, A. E. Miles, M. R. Uskokovic, J. Mansi, P. M. Stewart, L. P. O'Neill, B. M. Turner, K. W. Colston, et al. Altered nuclear receptor corepressor expression attenuates vitamin d receptor signaling in breast cancer cells. Clin. Cancer Res., April 1, 2006; 12(7): 2004 - 2013. [Abstract] [Full Text] [PDF]